Telix announces first patient dosed in Italy for its kidney cancer imaging agent, TLX250─CDx
Telix Pharmaceuticals Limited, a radiopharmaceutical company, develops molecularly targeted radiation products for unmet needs in cancer care in Australia, Belgium, Japan, and the US, announces that the first patient has been dosed in its named patient …